Abstract

Biofilm formation is a common strategy used by bacteria in order to survive and persist in the environment. In Vibrio cholerae (V. cholerae), a Gram-negative pathogen responsible for the cholera disease, biofilm-like aggregates are important for the pathogenesis and disease transmission. Biofilm formation is initiated by the attachment of the bacteria to a surface, followed by maturation stages involving the formation of a biofilm matrix. In V. cholerae, flagella are essential for the initial step of biofilm formation, allowing the bacteria to swim and to detect a surface. In this study, we explored the effect of polymyxin B (PmB), a cationic bacterial antimicrobial peptide, on biofilm formation in pathogenic V. cholerae strains belonging to the O1 and O139 serotypes. We found that sub-inhibitory concentration of PmB induces a reduction of the biofilm formation by V. cholerae O1 and O139. Experiment on preformed biofilm demonstrated that the biofilm formation inhibition occurs at the initial step of biofilm formation, where the flagella are essential. We further characterize the effect of PmB on V. cholerae flagellation. Our results demonstrate that the flagellin expression is not reduced in presence of sub-inhibitory concentration of PmB. However, a decrease of the abundance of flagellin associated with the bacterial cells together with an increase in the secretome was observed. Electron microscopy observations also suggest that the abundance of aflagellated bacteria increases upon PmB supplementation. Finally, in agreement with the effect on the flagellation, a reduction of the bacterial motility is observed. Altogether, our results suggest that the PmB affect V. cholerae flagella resulting in a decrease of the motility and a compromised ability to form biofilm.

Highlights

  • Vibrio cholerae is the causative agent of the cholera disease

  • We demonstrated that the association of the biofilm matrix protein Bap1 to the membrane vesicles is increased in presence of sub-inhibitory concentration of polymyxin B (PmB), a cationic bacterial Antimicrobial peptides (AMPs) produced by Bacillus polymyxa, leading to the cross-resistance with the human cathelicidin LL-37 [12]

  • In contrary to O1 classical strains, O1 El Tor strains and O139 strains are known to be resistant to PmB [36, 37] In this study, we have focused on the effect of sub-inhibitory concentration of PmB in the modulation of biofilm formation in V. cholerae O1 El Tor and O139

Read more

Summary

Introduction

Vibrio cholerae is the causative agent of the cholera disease. Infection usually occurs by consumption of food or water contaminated with V. cholerae. Antimicrobial peptides (AMPs) are oligopeptides of 12 to 50 amino-acids, mainly cationic and amphiphilic, with antimicrobial or immunomodulatory properties [25, 26] Because of their multiple intracellular and membrane targets in the bacterial cells, the development of resistance is expected to be limited [27]. In V. cholerae, our previous studies have clearly established that virulence and antimicrobial resistance proteins associated to membrane vesicles are up-regulated in response to the presence of sub-inhibitory concentrations of AMPs [12, 35]. We demonstrated that the association of the biofilm matrix protein Bap to the membrane vesicles is increased in presence of sub-inhibitory concentration of polymyxin B (PmB), a cationic bacterial AMP produced by Bacillus polymyxa, leading to the cross-resistance with the human cathelicidin LL-37 [12]. Using V. cholerae strains from both serogroups related to cholera disease, i.e. O1 and O139, we found that sub-inhibitory concentration of PmB can significantly impair V. cholerae biofilm formation during the initial adhesion step, by affecting the flagellar synthesis and shape

Materials and methods
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call